Thus it is concluded that TPP is a valuable tool for drugdevelopment when the marketing attributes are integrated within theframework of FDA’s definition of the TPP. This framework not onlyguides the clinical development decision, but also the foundationfor marketing success. It also contributes to the ultimate goal ofdriving greater efficiencies and shorter timelines to the approval of anoptimally marketable and profitable product.